» Articles » PMID: 26972644

Association Between Geographic Access to Cancer Care and Receipt of Radiation Therapy For Rectal Cancer

Abstract

Purpose: Trimodality therapy (chemoradiation and surgery) is the standard of care for stage II/III rectal cancer but nearly one third of patients do not receive radiation therapy (RT). We examined the relationship between the density of radiation oncologists and the travel distance to receipt of RT.

Methods And Materials: A retrospective study based on the National Cancer Data Base identified 26,845 patients aged 18 to 80 years with stage II/III rectal cancer diagnosed from 2007 to 2010. Radiation oncologists were identified through the Physician Compare dataset. Generalized estimating equations clustering by hospital service area was used to examine the association between geographic access and receipt of RT, controlling for patient sociodemographic and clinical characteristics.

Results: Of the 26,845 patients, 70% received RT within 180 days of diagnosis or within 90 days of surgery. Compared with a travel distance of <12.5 miles, patients diagnosed at a reporting facility who traveled ≥50 miles had a decreased likelihood of receipt of RT (50-249 miles, adjusted odds ratio 0.75, P<.001; ≥250 miles, adjusted odds ratio 0.46; P=.002), all else being equal. The density level of radiation oncologists was not significantly associated with the receipt of RT. Patients who were female, nonwhite, and aged ≥50 years and had comorbidities were less likely to receive RT (P<.05). Patients who were uninsured but self-paid for their medical services, initially diagnosed elsewhere but treated at a reporting facility, and resided in Midwest had an increased the likelihood of receipt of RT (P<.05).

Conclusions: An increased travel burden was associated with a decreased likelihood of receiving RT for patients with stage II/III rectal cancer, all else being equal; however, radiation oncologist density was not. Further research of geographic access and establishing transportation assistance programs or lodging services for patients with an unmet need might help decrease geographic barriers and improve the quality of rectal cancer care.

Citing Articles

The intersection of travel burdens and financial hardship in cancer care: a scoping review.

Planey A, Spees L, Biddell C, Waters A, Jones E, Hecht H JNCI Cancer Spectr. 2024; 8(5).

PMID: 39361410 PMC: 11519048. DOI: 10.1093/jncics/pkae093.


Sociodemographic and geographic factors impacting radiotherapy recommendation, initiation, and completion for patients with cancer.

Hogan J, Orav E, Vapiwala N, Lam M Cancer. 2024; 131(1):e35546.

PMID: 39233389 PMC: 11695155. DOI: 10.1002/cncr.35546.


Racial disparities in multiple myeloma and access to stem cell transplantation.

Cook J Blood Cancer J. 2024; 14(1):120.

PMID: 39039108 PMC: 11263617. DOI: 10.1038/s41408-024-01097-5.


Analysis of travel burden and travel support among patients treated at a comprehensive cancer center in the Southeastern United States.

Bai J, Barandouzi Z, Yeager K, Graetz I, Gong C, Norman M Support Care Cancer. 2024; 32(7):451.

PMID: 38907006 DOI: 10.1007/s00520-024-08656-3.


Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer.

Antar R, Xu V, Adesanya O, Drouaud A, Longton N, Gordon O Curr Oncol. 2024; 31(5):2566-2581.

PMID: 38785473 PMC: 11119047. DOI: 10.3390/curroncol31050192.


References
1.
Tepper J, OConnell M, Niedzwiecki D, Hollis D, Benson 3rd A, Cummings B . Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. J Clin Oncol. 2002; 20(7):1744-50. DOI: 10.1200/JCO.2002.07.132. View

2.
Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop W . An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer. Int J Radiat Oncol Biol Phys. 2003; 56(5):1295-307. DOI: 10.1016/s0360-3016(03)00423-1. View

3.
Meyerhardt J, Catalano P, Schrag D, Ayanian J, Haller D, Mayer R . Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med. 2003; 139(8):649-57. DOI: 10.7326/0003-4819-139-8-200310210-00008. View

4.
Delaney G, Barton M, Jacob S . Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence. Cancer. 2004; 101(4):657-70. DOI: 10.1002/cncr.20443. View

5.
Marijnen C, van de Velde C, Putter H, van den Brink M, Maas C, Martijn H . Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2005; 23(9):1847-58. DOI: 10.1200/JCO.2005.05.256. View